TgCRND8 Amyloid Precursor Protein Transgenic Mice Exhibit an Altered γ-Secretase Processing and an Aggressive, Additive Amyloid Pathology Subject to Immunotherapeutic Modulation
Authors:
- 18 August 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (36) , 10317-10327
Abstract
We investigated the morphology and biochemistry of the amyloid-β (Aβ) peptides produced in TgCRND8 Tg mice carrying combined amyloid precursor protein (APP) Swedish (K670M/N671L) and Indiana (V717F) mutations. Histological analyses employing amyloid-specific staining and electron microscopy revealed that the TgCRND8 Tg mice produce an aggressive pathology, evident as early as 3 months of age, that is a composite of core plaques and peculiar floccular diffuse parenchymal deposits. The Aβ peptides were purified using combined FPLC−HPLC, Western blots, and immunoprecipitation methods and characterized by MALDI-TOF/SELDI-TOF mass spectrometry. The C-terminal APP peptides, assessed by Western blot experiments and mass spectrometry, suggested an alteration in the order of secretase processing, yielding a C-terminal fragment pattern that is substantially different from that observed in sporadic Alzheimer's disease (AD). This modified processing pattern generated longer Aβ peptides, as well as those ending at residues 40/42/43, which may partially explain the early onset and destructive nature of familial AD caused by APP mutations. Despite an aggressive pathology that extended to the cerebellum and white matter, these animals tolerated the presence of an imposing amount of Aβ load. Aβ immunization resulted in an impressive 7-fold reduction in the number of amyloid core plaques and, as previously demonstrated, a significant memory recovery. However, given the phylogenetic distance and the differences in APP processing and Aβ chemistry between Tg mice and AD, caution should be applied in projecting mouse therapeutic interventions onto human subjects.Keywords
This publication has 16 references indexed in Scilit:
- Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease PatientsThe American Journal of Pathology, 2006
- Physiological roles for amyloid β peptidesThe Journal of Physiology, 2006
- Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy StudyJournal of Neuropathology & Experimental Neurology, 2005
- Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ42 Accumulation in a Novel Alzheimer Transgenic ModelThe American Journal of Pathology, 2004
- Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2004
- Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695Journal of Biological Chemistry, 2001
- Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.American Journal of Public Health, 1998
- Processing of β-Amyloid Precursor Protein by Cathepsin DJournal of Biological Chemistry, 1996
- Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s DiseaseJournal of Neuroscience, 1996
- Observations of amyloid angiopathy and senile plaques by the scanning electron microscopeActa Neuropathologica, 1979